Podcast: fighting counterfeits in Latin America and Caribbean

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Podcast: fighting counterfeits in Latin America and Caribbean

From left: Virginia Cervieri at Cervieri Monsuárez (Uruguay), André Oliveira at Daniel Law (Brazil) and Mikhail Jackson at Livingston Alexander & Levy (Jamaica)

Virginia Cervieri (Uruguay), André Oliveira (Brazil) and Mikhail Jackson (Jamaica) reveal their strategies for budget management, destruction and e-commerce




To listen to the full podcast, which is around one hour long, click the link above.

In Managing IP’s first LATAM and Caribbean podcast, Americas editor Patrick Wingrove speaks to Virginia Cervieri, co-founder at Cervieri Monsuárez in Uruguay, André Oliveira, partner at Daniel Law in Brazil, and Mikhail Jackson, partner at Livingston Alexander & Levy in Jamaica, about anti-counterfeiting.

Here, Cervieri, Oliveira and Jackson delve into anti-counterfeiting tactics and challenges surrounding budget management, destruction of fake products and e-commerce in their respective jurisdictions, and how those affect the rest of Latin America and the Caribbean.

more from across site and SHARED ros bottom lb

More from across our site

Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
In major recent developments, a confidentiality request was rejected, Samsung and its representative A&O Shearman secured a partial win, and EIP made a new hire
Tomas Wässingbo joins us for our ‘Five minutes with’ series to explain why he wants to change the perception around designs
PepsiCo was represented by PwC, while the Australian Taxation Office was advised by Australian-headquartered law firm MinterEllison
The firm said revenue from its ‘refreshed and expanded’ IP team increased by 4% in FY25
As revenue reporting season hits full stride, firms have made a point of highlighting the successes of their IP teams as they take centre stage in big-ticket work
GSK and CureVac will together receive $740 million, as well as royalties on sales of COVID-19 vaccines in the US
The firm, which represented Getty in one of the most closely followed copyright cases in recent years, said IP was among its standout practice areas
The decision to divide was partly due to differing visions over the impact of technology on IP work, according to one partner
Gift this article